Retrospective Review of Chemotherapy Treatment for Locally Advanced and Metastatic Penile Cancer in the North West of England

Cliff, Joanne; Britten, Anna; Innes, Helen; Mehmood, Q.; Birtle, Alison; Elliott, Tony

doi:10.9734/bjmmr/2015/14391

BJMMR

2015

DOI: 10.9734/bjmmr/2015/14391

|View full text |Cite

Retrospective Review of Chemotherapy Treatment for Locally Advanced and Metastatic Penile Cancer in the North West of England

Joanne Cliff

Anna Britten

Helen Innes

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2022

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Chemotherapeutic regimens.Lines of Therapy in Penile Carcinoma based on various studies [11][12][13]. …”

mentioning

confidence: 99%

Penile carcinoma: Multi-options possible requirements

Chaudhry¹

2022

IJCAAP

View full text Add to dashboard Cite

There is a relatively higher incidence of penile cancer in India 3.32 per 100 000 men, whereas Jewish men have the lowest incidence. The risk factors include phimosis, balanitis, and no circumcision. Human papillomavirus accounts for 40% of cases. Other factors include obesity, smoking, Psoralen UV- A therapy. Penile cancer is common above the age of 50 years. 95% of penile cancer is a squamous cell, carcinoma. Treatment of Penile carcinoma is stage wise, where surgery, partial or total penectomy, radiation therapy, or chemotherapy are a mainstay. Laser therapy is often used in the treatment of both CIS and low-grade/stage invasive disease. The neoadjuvant regimen often used is TIP, which consists of 4 cycles of paclitaxel, ifosfamide, and cisplatin. Nimotuzumab EGFR-antibody treatment as an alternative salvage treatment for advanced penile cancer. Immune Checkpoints blockades such as cabozantinib are evaluated in resistant diseases. Avelumab is currently tested in penile cancer patients in two ongoing trials.

show abstract

“…Chemotherapeutic regimens.Lines of Therapy in Penile Carcinoma based on various studies [11][12][13]. …”

mentioning

confidence: 99%

Penile carcinoma: Multi-options possible requirements

Chaudhry¹

2022

IJCAAP

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Retrospective Review of Chemotherapy Treatment for Locally Advanced and Metastatic Penile Cancer in the North West of England

Cited by 1 publication

References 19 publications

Penile carcinoma: Multi-options possible requirements

Penile carcinoma: Multi-options possible requirements

Contact Info

Product

Resources

About